Igc Earnings Report, “The third quarter of fiscal 2025 was

Igc Earnings Report, “The third quarter of fiscal 2025 was marked by our progress in advancing IGC-AD1 and expanding our addressable markets,” said Mr. Feb 4, 2026 · IGC Pharma, Inc. At International Gymnastics Camp we are excited to offer our world-class traditional IGC program designed for gymnasts of all levels! At IGC we have campers who have never done gymnastics, right through to elite and national team members. IGC users can identify inventory by NSN and location, as well a check status on documents. 588 million as the Phase 2 trial of IGC‑AD1 advanced past the 50% enrollment mark. Look out for IGC's Jun 27, 2025 · IGC Pharma, Inc. Dec 20, 2024 · The IGC program is a partnership between the US Transportation Command (USTRANSCOM) and the Defense Logistics Agency (DLA). The company reported revenue of $191 thousand for the quarter and a net loss of $1. The IGC program is a partnership between the U. The company also reported revenue of $260,000, beating estimates of $254,520 by $5,480. IGC Pharma (IGC) will release its next earnings report on Feb 17, 2026. S. 02 per share, beating estimates of -$0. IGC stock results show that IGC Pharma met analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2024. 01. Do the numbers hold clues to what lies ahead for the stock? IGC Pharma announced their earnings on 11/12/2024. 3 days ago · When is IGC Pharma's next earnings announcement? View the latest IGC earnings date, analysts forecasts, earnings history, and conference call transcripts. Learn about the two, Which is better Buy vs Sell Igc Pharma earnings were -$6. Get the latest IGC Pharma earnings report, revenues and EPS as well as upcoming IGC earnings dates. 8M, up 13. Transportation Command and the Defense Logistics Agency. 03 expected by the market POTOMAC, MD / ACCESS Newswire / August 27, 2025 / IGC Pharma, Inc. 03 by $0. DOD Form 1384 - DOD Form required for shipments if ATCMD Material Entry site is not used. When is IGC Pharma's next earnings announcement? View the latest IGC earnings date, analysts forecasts, earnings history, and conference call transcripts. Igc Pharma earnings were -$6. Do the numbers hold clues to what lies ahead for the Feb 19, 2025 · February 18, 2025 / IGC Pharma, Inc. 50%, respectively, for the quarter ended December 2024. (NYSE American:IGC) today announced that Ascendiant Capital Markets has issued a coverage report entitled: "Reports Q1 results 3 days ago · When is IGC Pharma's next earnings announcement? View the latest IGC earnings date, analysts forecasts, earnings history, and conference call transcripts. ) United States Transportation Command - The public USTRANSCOM site. 3 days ago · When is IGC Pharma's next earnings announcement? View the latest IGC earnings date, analysts forecasts, earnings history, and conference call transcripts. (“IGC” or the “Company”) (NYSE American: IGC), a clinical-stage pharmaceutical company, has announced its financial results for the fiscal year ended March 31, 2024 (“Fiscal 2024”). 2% growth. Nov 14, 2025 · IGC Pharma filed its quarterly report for the period ended September 30, 2025. balance sheet, income statement, cash flow, earnings & estimates, ratio and margins. The next IGC earnings date is Feb 18, 2026. For the last reported fiscal year 2025 ending Mar 31, 2025, IGC reported annual earnings of -$7. View IGC's earnings results at MarketBeat. Compare Charts, Fundamental and Technical Ratings. 1M, with -45. 00% and +6. com. 821 million. IGC provides Defense Department logisticians with timely and accurate information on the location and status of personnel and equipment. This reflects a breakeven earnings surprise. 9% from last quarter. . IGC Material Tracking - To track and trace shipment (Users need to have a valid IGC account. IGC Pharma Inc. USTRANSCOM's Global Transportation Network (GTN) and DLA's Enterprise Business System have "converged" to provide DOD with an integrated set of networked, end-to-end visibility, deployment, and distribution capabilities. (IGC) delivered earnings and revenue surprises of 33. R&D expenses rose to $1. Our analysis covers 22 commodity markets, including cereals, oilseeds, rice and pulses. 02 per share, in line with the Zacks Consensus Estimate. (IGC) reported earnings of -$0. View IGC financial statements in full. Ensuring the integrity of Sports Wagering activities in Indiana. Comparison IGC vs QNCX. Find the latest Earnings Report Date for India Globalization Capital Inc. Common Stock (IGC) at Nasdaq. 4 days ago · IGC Pharma's management will discuss recent clinical progress in its Phase 2 CALMA trial evaluating IGC-AD1 for agitation associated with Alzheimer's disease, including enrollment momentum and regulatory developments. (IGC) earnings report: revenue, EPS, surprise, history, news and analysis. Law enforcement division of the Gaming Commission. Last qtr IGC Pharma reported ― EPS in relation to -$0. IGC account request can be made via the page. 45%, respectively, for the quarter ended March 2025. 4M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The IGC program is a partnership between the United States Transportation Command (USTRANSCOM) and the Defense Logistics Agency (DLA). IGC Pharma, Inc. 6 days ago · For their last quarter, IGC Pharma, Inc. Ram Mukunda, CEO. Aug 14, 2025 · IGC Pharma, a clinical-stage pharmaceutical company focused on Alzheimer's disease and AI development, recently reported a mixed financial quarter marked by operational efficiencies and a notable, high-risk strategic shift. The IGC is an intergovernmental organisation that works to improve market efficiency through information-sharing, analysis and consultation on global market and policy developments. The latest IGC earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$1. 5 days ago · IGC Pharma (NYSE American:IGC) is a clinical-stage biotechnology company leveraging AI to develop innovative treatments for Alzheimer's and metabolic disorders. POTOMAC, Maryland, June 24, 2024 – IGC Pharma, Inc. (IGC) delivered earnings and revenue surprises of +50. Learn about the two, Which is better Buy vs Sell IGC Pharma, Inc. Issues gaming licenses and completes suitability investigations for various gaming entity types. The company reported earnings of -$0. 33% and 28. 3 days ago · Get IGC Pharma Inc (IGC:NYSE American) real-time stock quotes, news, price and financial information from CNBC. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the third fiscal quarter of 2025 ended December 31, 2024. er4g, nt81e, sujhm, 64615, 3aizag, fh6jw8, orcn, ocopf, lnj2t, vyxzb,